cloricromen has been researched along with calcimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goracci, G; Gresele, P; Mezzasoma, AM; Nenci, GG; Prosdocimi, M; Quero, E; Ribaldi, E; Stasi, M | 1 |
| Francescangeli, E; Goracci, G; Gresele, P; Mezzasoma, AM; Nenci, GG; Prosdocimi, M; Ribaldi, E | 1 |
2 other study(ies) available for cloricromen and calcimycin
| Article | Year |
|---|---|
Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipids.
Topics: Arachidonic Acid; Calcimycin; Chromonar; Dose-Response Relationship, Drug; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Membrane Lipids; Neutrophils; Phospholipids; SRS-A; Zymosan | 1993 |
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
Topics: Acetyltransferases; Calcimycin; Chromonar; Diacylglycerol Cholinephosphotransferase; Enzyme Activation; Humans; In Vitro Techniques; Indicators and Reagents; Ionophores; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors | 1996 |